retatrutide trial of next-gen weight-loss drug brings it one step closer to FDA approval Diabetes Dialogue: Retatrutide Reduces Body

The starting dose in clinical trials is 1 mg once weekly

In Phase 3 TRIUMPH-1 data, dysesthesia occurred in 5.1%, 12.3%, and 12.5% of participants taking retatrutide 4 mg, 9 mg, and 12 mg, compared with 0.9% of participants receiving placebo

the study revealed people who lived in underserved health regions were less likely to complete 12 weeks of treatment

Once prescribed by our medical providers, your prescription is sent to our partner GLP-1 compounding pharmacy (or in some cases, another pharmacy of your choosing)

A lot of times its sold in a multiuse vial, and so you can, without intention, give yourself five times the dose, says Dr

Our bulk options are ideal for clinical trials, research projects, or commercial manufacturing